Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
Anxiety: Overview01:18

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Social Anxiety Disorder01:28

Social Anxiety Disorder

Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential susceptibility of hair colour changes after barzolvolimab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria.

The Journal of allergy and clinical immunology·2026
Same author

Psychiatric Comorbidities and Weight Loss Recommendations in Bariatric Surgery Patients.

Rhode Island medical journal (2013)·2025
Same author

On the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition.

Allergy·2025
Same author

Variables Associated With Non-Response in Anxiety and Depression Among Patients Receiving Treatment in a Partial Hospitalization Program.

Journal of clinical psychology·2025
Same author

Anti-KIT Barzolvolimab for Chronic Spontaneous Urticaria.

Allergy·2025

Related Experiment Videos

A clinically useful anxiety outcome scale.

Mark Zimmerman1, Iwona Chelminski, Diane Young

  • 1Bayside Medical Center, 235 Plain St, Providence, RI 02905, USA. mzimmerman@lifespan.org

The Journal of Clinical Psychiatry
|April 6, 2010
PubMed
Summary

The Clinically Useful Anxiety Outcome Scale (CUXOS) is a reliable, valid, and quick anxiety measure suitable for routine psychiatric care. This anxiety scale demonstrates feasibility for clinical practice.

Related Experiment Videos

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Psychometrics

Background:

  • Standardized scales are crucial for measuring treatment outcomes in psychiatric disorders.
  • Incorporating feasible and psychometrically sound measures into routine clinical practice is essential for improving patient care.

Purpose of the Study:

  • To describe the reliability and validity of the Clinically Useful Anxiety Outcome Scale (CUXOS).
  • To assess the feasibility of the CUXOS for routine clinical use.

Main Methods:

  • Nearly 1,000 psychiatric outpatients completed the CUXOS.
  • Clinician severity indices and other self-report scales were used to assess validity.
  • Test-retest reliability and sensitivity to change were examined in specific patient groups.

Main Results:

  • The CUXOS is brief, taking under 1.5 minutes to complete and 15 seconds to score.
  • The scale demonstrated high internal consistency and test-retest reliability.
  • CUXOS showed strong correlations with anxiety measures and was sensitive to symptom change.

Conclusions:

  • The Clinically Useful Anxiety Outcome Scale (CUXOS) is a reliable and valid measure for assessing anxiety.
  • The CUXOS is feasible for integration into routine clinical practice for psychiatric disorders.